BEOVU
NDC 0078-0827, brolucizumab, injection, solution, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0827
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761125
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BROLUCIZUMAB6 mg/.05mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0827-60 | 00078082760 | 1 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASS |
| 0078-0827-98 | 00078082798 | 1 SYRINGE, GLASS in 1 CARTON (0078-0827-98) / .05 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0078-0827
Use it
Look up 0078-0827 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0827 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.